These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

255 related articles for article (PubMed ID: 35968783)

  • 21. Clinical significance of fibroblast-specific protein-1 expression on podocytes in patients with focal segmental glomerulosclerosis.
    Samejima K; Nakatani K; Suzuki D; Asai O; Sakan H; Yoshimoto S; Yamaguchi Y; Matsui M; Akai Y; Toyoda M; Iwano M; Saito Y
    Nephron Clin Pract; 2012; 120(1):c1-7. PubMed ID: 22126861
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Gα12 activation in podocytes leads to cumulative changes in glomerular collagen expression, proteinuria and glomerulosclerosis.
    Boucher I; Yu W; Beaudry S; Negoro H; Tran M; Pollak MR; Henderson JM; Denker BM
    Lab Invest; 2012 May; 92(5):662-75. PubMed ID: 22249312
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Fn14 in podocytes and proteinuric kidney disease.
    Sanchez-Niño MD; Poveda J; Sanz AB; Mezzano S; Carrasco S; Fernandez-Fernandez B; Burkly LC; Nair V; Kretzler M; Hodgin JB; Ruiz-Ortega M; Selgas R; Egido J; Ortiz A
    Biochim Biophys Acta; 2013 Dec; 1832(12):2232-43. PubMed ID: 23999007
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Glomerular endothelial cell injury and focal segmental glomerulosclerosis lesion in idiopathic membranous nephropathy.
    Morita M; Mii A; Shimizu A; Yasuda F; Shoji J; Masuda Y; Ohashi R; Nagahama K; Kaneko T; Tsuruoka S
    PLoS One; 2015; 10(4):e0116700. PubMed ID: 25875837
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Podocyte-specific RAP1GAP expression contributes to focal segmental glomerulosclerosis-associated glomerular injury.
    Potla U; Ni J; Vadaparampil J; Yang G; Leventhal JS; Campbell KN; Chuang PY; Morozov A; He JC; D'Agati VD; Klotman PE; Kaufman L
    J Clin Invest; 2014 Apr; 124(4):1757-69. PubMed ID: 24642466
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Podocyte injury-driven lipid peroxidation accelerates the infiltration of glomerular foam cells in focal segmental glomerulosclerosis.
    Hara S; Kobayashi N; Sakamoto K; Ueno T; Manabe S; Takashima Y; Hamada J; Pastan I; Fukamizu A; Matsusaka T; Nagata M
    Am J Pathol; 2015 Aug; 185(8):2118-31. PubMed ID: 26072030
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Mechanisms and consequences of TGF-ß overexpression by podocytes in progressive podocyte disease.
    Lee HS
    Cell Tissue Res; 2012 Jan; 347(1):129-40. PubMed ID: 21541658
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Loss of the podocyte-expressed transcription factor Tcf21/Pod1 results in podocyte differentiation defects and FSGS.
    Maezawa Y; Onay T; Scott RP; Keir LS; Dimke H; Li C; Eremina V; Maezawa Y; Jeansson M; Shan J; Binnie M; Lewin M; Ghosh A; Miner JH; Vainio SJ; Quaggin SE
    J Am Soc Nephrol; 2014 Nov; 25(11):2459-70. PubMed ID: 24904088
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Role of podocytes for reversal of glomerulosclerosis and proteinuria in the aging kidney after endothelin inhibition.
    Ortmann J; Amann K; Brandes RP; Kretzler M; Münter K; Parekh N; Traupe T; Lange M; Lattmann T; Barton M
    Hypertension; 2004 Dec; 44(6):974-81. PubMed ID: 15545511
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Inhibiting NLRP3 signaling in aging podocytes improves their life- and health-span.
    Kaverina N; Schweickart RA; Chan GC; Maggiore JC; Eng DG; Zeng Y; McKinzie SR; Perry HS; Ali A; O'Connor C; Pereira BMV; Theberge AB; Vaughan JC; Loretz CJ; Chang A; Hukriede NA; Bitzer M; Pippin JW; Wessely O; Shankland SJ
    Aging (Albany NY); 2023 Jul; 15(14):6658-6689. PubMed ID: 37487005
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The Hippo pathway regulator KIBRA promotes podocyte injury by inhibiting YAP signaling and disrupting actin cytoskeletal dynamics.
    Meliambro K; Wong JS; Ray J; Calizo RC; Towne S; Cole B; El Salem F; Gordon RE; Kaufman L; He JC; Azeloglu EU; Campbell KN
    J Biol Chem; 2017 Dec; 292(51):21137-21148. PubMed ID: 28982981
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Activation of Notch3 in Glomeruli Promotes the Development of Rapidly Progressive Renal Disease.
    El Machhour F; Keuylian Z; Kavvadas P; Dussaule JC; Chatziantoniou C
    J Am Soc Nephrol; 2015 Jul; 26(7):1561-75. PubMed ID: 25421557
    [TBL] [Abstract][Full Text] [Related]  

  • 33. AMPK mediates regulation of glomerular volume and podocyte survival.
    Banu K; Lin Q; Basgen JM; Planoutene M; Wei C; Reghuvaran AC; Tian X; Shi H; Garzon F; Garzia A; Chun N; Cumpelik A; Santeusanio AD; Zhang W; Das B; Salem F; Li L; Ishibe S; Cantley LG; Kaufman L; Lemley KV; Ni Z; He JC; Murphy B; Menon MC
    JCI Insight; 2021 Oct; 6(19):. PubMed ID: 34473647
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Activation of NFAT signaling in podocytes causes glomerulosclerosis.
    Wang Y; Jarad G; Tripathi P; Pan M; Cunningham J; Martin DR; Liapis H; Miner JH; Chen F
    J Am Soc Nephrol; 2010 Oct; 21(10):1657-66. PubMed ID: 20651158
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Integrin beta1-mediated matrix assembly and signaling are critical for the normal development and function of the kidney glomerulus.
    Kanasaki K; Kanda Y; Palmsten K; Tanjore H; Lee SB; Lebleu VS; Gattone VH; Kalluri R
    Dev Biol; 2008 Jan; 313(2):584-93. PubMed ID: 18082680
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Assessment of urinary angiotensinogen as a marker of podocyte injury in proteinuric nephropathies.
    Eriguchi M; Yotsueda R; Torisu K; Kawai Y; Hasegawa S; Tanaka S; Noguchi H; Masutani K; Kitazono T; Tsuruya K
    Am J Physiol Renal Physiol; 2016 Feb; 310(4):F322-33. PubMed ID: 26632605
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Ubiquitin C-terminal hydrolase L1 deletion ameliorates glomerular injury in mice with ACTN4-associated focal segmental glomerulosclerosis.
    Read NC; Gutsol A; Holterman CE; Carter A; Coulombe J; Gray DA; Kennedy CR
    Biochim Biophys Acta; 2014 Jul; 1842(7):1028-40. PubMed ID: 24662305
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Ret is critical for podocyte survival following glomerular injury in vivo.
    Hou G; Wu V; Singh G; Holzman LB; Tsui CC
    Am J Physiol Renal Physiol; 2015 Apr; 308(7):F774-83. PubMed ID: 25587123
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Vangl2, a planar cell polarity molecule, is implicated in irreversible and reversible kidney glomerular injury.
    Papakrivopoulou E; Vasilopoulou E; Lindenmeyer MT; Pacheco S; Brzóska HŁ; Price KL; Kolatsi-Joannou M; White KE; Henderson DJ; Dean CH; Cohen CD; Salama AD; Woolf AS; Long DA
    J Pathol; 2018 Dec; 246(4):485-496. PubMed ID: 30125361
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Melanocortin therapy ameliorates podocytopathy and proteinuria in experimental focal segmental glomerulosclerosis involving a podocyte specific non-MC1R-mediated melanocortinergic signaling.
    Qiao Y; Wang P; Chang M; Chen B; Ge Y; Malhotra DK; Dworkin LD; Gong R
    Clin Sci (Lond); 2020 Apr; 134(7):695-710. PubMed ID: 32167144
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.